1-O-palmitylglucuronic acid

Known as: 1-O-palmityl-D-glucuronic acid, PGlcUA, palmitoyl glucuronide 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1990-1998
01219901998

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
  • Oku
  • Advanced drug delivery reviews
  • 1999
Liposomes encapuslating positron emitters are applicable for diagnostic imaging and are useful to investigate the real-time… (More)
Is this relevant?
1999
1999
  • Oku
  • Advanced drug delivery reviews
  • 1999
Since conventional liposomes tend to be trapped by the reticuroendothelial systems (RES), their use as drug carriers is limited… (More)
Is this relevant?
1996
1996
Liposomes modified with the uronic acid derivative palmityl-D-glucuronide (PGlcUA) have a long circulation time and tend to… (More)
Is this relevant?
1996
1996
Various kinds of long-circulating liposome, such as ganglioside GM1-, polyethyleneglycol- (PEG-), and glucuronide-modified… (More)
Is this relevant?
1995
1995
Long-circulating liposomes are known to accumulate passively in tumor tissues of tumor-bearing animals. To evaluate the in vivo… (More)
Is this relevant?
1994
1994
Long-circulating liposomes modified with a uronic-acid derivative, palmityl-D-glucuronide (PGIcUA), have been developed… (More)
Is this relevant?
1994
1994
Reticuloendothelial system (RES)-avoiding liposomes are known to accumulate in tumor tissues due to passive targeting… (More)
Is this relevant?
1993
1993
For passive targeting of liposomes to tumor tissues, we earlier developed reticuloendothelial system (RES)-avoiding liposomes… (More)
Is this relevant?
1992
1992
For passive targeting of liposomes to tumor tissues, we earlier developed reticuloendothelial system (RES)-avoiding liposomes… (More)
Is this relevant?
1990
1990
For the purpose of obtaining liposomes with long circulation time in blood, we synthesized 1-O-palmityl-D-glucuronic acid (PGlcUA… (More)
Is this relevant?